Addictions: a major Public Health threat

Huge medical need : not well addressed by present solutions

a socio economic problem

Addiction is a huge problem we try to solve. The market is more than 3 billion USD and involve more than 35M people.

In a regulatory point of view, the addiction was finally recognized as a real chronic pathology of the central nervous system in August, 2011 by the American Society for Addiction Medicine and validated by NIDA.

Addiction market estimations

  • 63 million people are affected by alcohol-dependence in USA and in Europe.
  • 3,3 million deaths every year in the world are attributable to the alcohol abuse.
  • Healthcare costs: more than 5 % of the world load of the diseases and traumas.
  • 3,3 million deaths every year in the world are attributable to the alcohol abuse.
  • In France social cost : 120 bio for alcohol and 120 bio for tobacco.
  • Today anti addiction drug market 1.5 € bio (+20%/year)?

Deal realized in 2011 in the
field of the addiction

It concerns Biotie and Lundbeck companies for Selincro (Nalmefene) at the end of 2011 in phase 2:

  • Upfront : 12 million euros
  • Milestones : 84 million euros
  • Royalties : not revealed
  • Royalties : not revealed

Last realized deal (2013)

It concerns XenoPort companies and Reckitt Benckiser for Arbaclofen in phase 2:

  • Upfront : 25 million USD
  • Milestones : 70 million USD + 50 million USD
  • Royalties : not revealed